Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

The Vanguard Study: Testing a New Way to Screen for Cancer

for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Portsmouth VA, Norfolk VA, Bethesda MD, Richmond VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 45 - 70+

Code: NCT06995898

Recruiting

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

for
Mesothelioma, Neoplasms, Stomach Neoplasms,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06885697

Phase 1, Recruiting

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer

for
Lung Carcinoma, Malignant Respiratory Tract Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03422302

Recruiting

RAPA-201 Therapy of Solid Tumors

for
Solid Tumor, Small Cell and Non-small Cell Lung Cancer,
Location: Hackensack NJ
Sponsor: Rapa Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05144698

Phase 1, Phase 2, Recruiting

Adapting the Tumor Board Model for Mental Illness and Cancer

for
Cancer, Severe Major Depression, Schizophrenia,
Location: Danvers MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05837598

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

for
Breast Cancer, Colorectal Cancer, Pancreas Cancer,
Location: Kingston, Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05403177

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

for
Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer,
Location: Toronto, Pittsburgh PA, Milwaukee WI, Houston TX
Sponsor: UMC Utrecht

Sex: All

Age: 18+

Code: NCT04075305

Recruiting

Biomarkers of Resiliency In Childhood Cancer Surgery

for
Pediatric Cancer, Neuroblastoma, Sarcoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 3 - 25

Code: NCT06674811

Recruiting

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

for
Bladder Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 18+

Code: NCT03740256

Phase 1, Recruiting

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Halifax, Montreal, Toronto, Calgary, Vancouver
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT06960291

Recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

for
Non-Small Cell Lung Cancer,
Location: Boston MA, The Bronx NY, Washington D.C. DC, Fairfax VA,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05256290

Phase 1, Phase 2, Recruiting

Confocal Laser Endomicroscopy VERification

for
Lung Cancer, Lung Neoplasm Malignant,
Location: New York NY
Sponsor: Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Sex: All

Age: 18+

Code: NCT06079970

Recruiting

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

for
Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05068232

Phase 2, Recruiting

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06122064

Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase 1, Phase 2, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: New Haven CT, Norwalk CT, New York NY, Montreal,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Sherbrooke, Chicoutimi, Nyack NY, Albany NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT05292521

Recruiting

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04762199

Phase 1, Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for
Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer,
Location: New York NY, Miami FL, Pittsburgh PA, Orlando FL,
Sponsor: Obsidian Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06060613

Phase 1, Phase 2, Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial